Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,701–2,800 of 2,883
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
ПОИСК НОВОГО ГЕРОПРОТЕКТОРА: ИССЛЕДОВАНИЕ ВЛИЯНИЯ ФУКОКСАНТИНА НА МАРКЕРЫ СТАРЕНИЯ У МЫШЕЙ
Капралов, А. И., Маклакова, И. Ю., Гребнев, Д. Ю., & Базарный, В. В. (2025) · Успехи геронтологии · doi:10.34922/ae.2025.38.4.014
González-Meljem, J. M., Haston, S., Gallage, S., Innes, A. J., & Scheckhuber, C. Q. (2024) · Springer eBooks · doi:10.1007/978-3-031-76469-1_2
Lyamina, S., Валерьевич, К. С., Kozhevnikova, E. O., & Павловна, Л. Н. (2026) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2026-15-2-122-137 · Cited by 1
Usando Biologia de Sistemas para entender a Imunossenescência
Passos, F. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.95.2018.tde-20230725-114626
Senescence: A new kid in the block of the metabolic response to surgical trauma
Laviano, A. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.107048
Monitoring senescent cell dynamics in wound healing using a p16-tdtomato mouse model
Wang, Q., Shvedova, M., Abdelkader, M., & Roh, D. S. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.12.029
Suppressing p16INK4a promotes lung regeneration through a fibroblast lipogenic switch
Zysman, M. (2019) · theses.fr (ABES) · doi:10.70675/c507eaa0z188ez4332z952az2c54118917d6
Faragher, R., Freimann, A., & Ruß, J. (2026) · Insurance Mathematics and Economics · doi:10.1016/j.insmatheco.2026.103230 · Cited by 1
Old Cells Need New Rules: New Guidelines for Senescent Cell Experimentation In Vivo
Грубер, Ф., & Kremslehner, C. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.10.590
Schumacher, B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733897159.793563342
Ikuno, Y., Watanabe, K., Kakeya, Y., Ikeno, S., Nakabo, T., Narumoto, A., Kande, Y., Hayashi, T., Minami, K., Nobuhiro, K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2204556/v2
The dual role of cellular senescence in tumor occurrence and development
Huang, X., Wang, Z.-R., Wu, B., & Song, W.-W. (2025) · Discover Medicine · doi:10.1007/s44337-025-00502-7
Samad, N., Hafeez, F., & Imran, I. (2021) · doi:10.21203/rs.3.rs-158433/v1
Clearance of senescent cells: potent anti-aging approach
Ferreira, J., & Deamer, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90235-9.00002-1
Yang, J., Han, H., Wang, X., & Suh, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.679215 · Cited by 1
Pioger, A., Martin, N., Abbadie, C., & Dehennaut, V. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189665
Morris, B. J., Willcox, B. J., & Donlon, T. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_429
Josipović, N. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9136 · Cited by 1
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G. B., Campisi, J., & Rodier, F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/413732
Senescence of endplate osteoclasts induces sensory innervation and spinal painPreprint
Pan, D., Benkato, K. G., Han, X., Zheng, J., Kumar, V., Wan, M., Zheng, J., & Cao, X. (2024) · eLife · doi:10.7554/elife.92889.2
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Characterization of p16-positive stromal cells in age-related cardiac disorders
Morimura, T., Wang, T.-W., Kawakami, S., & Nakanishi, M. (2026) · The Journal of Biochemistry · doi:10.1093/jb/mvag013
“The genetic or pharmacological elimination of senescent cells has been reported to ameliorate aging phenotypes in multiple organs, including the heart ( 3 , 4 ).”
Physiologie et physiopathologie de la sénescence
Swynghedauw, B. (2018) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2018.03.001 · Cited by 1
Takauji, Y., Tanabe, K., Miyashita, H., Katakawa, T., Fujii, S., Sugimoto, M., En, A., Ayusawa, D., & Fujii, M. (2026) · FEBS Journal · doi:10.1101/2025.03.03.641349
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases
Liu, R.-M., & Nakamya, M. F. (2026) · Cells · doi:10.3390/cells15060551 · Cited by 1
An antibiotic that mediates immune destruction of senescent cancer cellsPreprint
Raffi, G. C., Chen, J., Feng, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.05.611241
Analysis of SASP Factors Derived from Senescent Osteoblasts Induced by LPS
Igarashi, N. (2021) · THE JOURNAL OF THE STOMATOLOGICAL SOCIETY JAPAN · doi:10.5357/koubyou.88.1_49
Cellular senescence by loss of Men1 in osteoblasts is critical for age-related osteoporosisPreprint
Kaito, T., Ukon, Y., Hirai, H., Kitahara, T., Bun, M., Kodama, J., Tateiwa, D., Nakagawa, S., Ikuta, M., Furuichi, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2798820/v1
Senescence Gene Expression Profiles and 90-Day Outcome in Stroke Patients
Real, M. G. C., Zhang, Y., Falcione, S. R., Joy, T., Clarke, M. D., Habashi, S. A., Alavi, P., McFeetors, R., Boghozian, R., & Jickling, G. C. (2026) · Neurology · doi:10.1212/wnl.0000000000218295
Basic Hematopoiesis and Leukemia Stem Cells
Hwang, W. Y. K., Bari, S., Ng, L. G., Itahana, K., Li, S., Koh, J. Y. P., & Than, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_1
Möller, S., Barrantes, I., Jaster, R., Henze, L., Escobar, H. M., Junghanß, C., Hakenberg, O. W., Weber, M., Krause, B. J., Wolkenhauer, O., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/404525
Kartha, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85536-9_12
Stress-induced senescence of tubular cells
Baird, D., Ferenbach, D. A., & Bonventre, J. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00037-8
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Sirtuin 3 is required for pro-inflammatory and pro-regenerative aspects of senescent cellsPreprint
Wiley, C. D., Mogck, B. A., Jezak, S. T., & Velarde, M. C. (2024) · Research Square · doi:10.21203/rs.3.rs-4656269/v1
Targeting cellular senescence for cancer therapy
Abduljabbar, R., Liu, Y., Mussa, A., Abdu, A. M. A., Man, Y., Chen, Q., & Liu, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126297 · Cited by 1
Modulating senescence for therapeutic delivery
Liu, Y., & Hu, Q. (2026) · Med-X · doi:10.1007/s44258-026-00093-7
Csoka, A. B., Stambler, I., West, M. D., Heinbockel, T., Bhowmik, D., Herbig, U., & Stair, S. E. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-20006-8_9
Systemic Senolysis in Naturally Aged Mice Using a FAST-PLV Gene Therapy ApproachPreprint
Lewis, J. D., Garcia, H., Brown, D., Raturi, A., Nehme, J., Bhandari, P., Wee, P., Malavolta, M., Grin, L., Vega, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5575296/v1
The Relevance of Induced Pluripotent Stem Cells for the Study of Physiological and Premature Aging
Carrero, D., & López-Otín, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_13
Senotherapy as a Novel Therapeutic Method in Cancer Treatment: With a Focus on Head and Neck Cancer
Ziaei, H., & Harada, H. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_118
The role of melanocyte senescence in skin ageing
Victorelli, S. G. (2018)
Robust Design Of Transmit Pulse Shape
Vo, B., & Cantoni, A. (2015) · UWA Profiles and Research Repository (University of Western Australia) · doi:10.5281/zenodo.37180
The Molecular Physiology of Ageing: New Targets for Regenerative Medicine
Macip, S., & Althubiti, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-15458-5_3
Furman, A. M. (2026) · University of Michigan Undergraduate Research Journal · doi:10.3998/umurj.9826
Cheung, N. (2026) · Cureus · doi:10.7759/cureus.109147
“Cellular senescence and inflammaging are hallmarks of aging and contribute to tissue dysfunction [25,60-62]. p16Ink4a-positive senescent cells have been shown to shorten healthy lifespan [63].”
Bat-Inspired Longevity: Immune Damage Management and Nutritional Modulation for Healthy Aging
Park, S., & Daily, J. W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104467
“Perforin-deficient mice exhibit accelerated senescent cell accumulation, chronic inflammation, and shortened lifespan—conditions reversed by senolytics—supporting the causal importance of this clearance capacity [63].”
Senotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
Phase-transition failure in aged skeletal muscle regeneration
Zhang, B., Shi, H., Guo, X., & Wang, Y. (2026) · Biogerontology · doi:10.1007/s10522-026-10500-6
“Genetic clearance of p16-positive cells, dasatinib plus quercetin (D+Q), and exercise training each improve homeostatic readouts, and without post-injury longitudinal endpoints an improved baseline stays indistinguishable from a restored repair program (Baker et al. 2016; Xu et al. 2018).”
Elmasry, F. E., El‐Deeb, O. S., Gaballah, H. H., & Allah, A. A. A. (2021) · Tanta Medical Journal · doi:10.4103/tmj.tmj_25_21
Prokopov, A., Дробинцева, А. О., Любякина, П. Н., & Kvetnoy, I. M. (2026) · Успехи геронтологии · doi:10.34922/ae.2026.39s
HD-PTP/PTPN23 hypomorphic mice display lipodystrophyPreprint
Davies, B. A., Payne, J. A., Martin, C. P., Schultz, D. F., Childs, B. G., Zhang, C., Jeganathan, K. B., Sturmlechner, I., White, T. A., de Bruin, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.02.502401
Self-citationSenescent Subtypes Transition ModelPreprint
Singh, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.10.544466
“On the detrimental side, cellular senescence can also drive tumour growth and age-related disease progression [12].”
BackgroundCaravello, A., & Blidy, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1861044
“The senescent marrow environment is causally implicated in progenitor dysfunction, since clearance of senescent cells rejuvenates aged hematopoietic stem cells (37, 61).”
Prevention and Treatment of the Troubles of the Elderly
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_8
Sharoni, E. Y. (2021) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16 INK4A
Göbl, C., Morris, V. K., van Dam, L., Visscher, M., Polderman, P. E., Hartlmüller, C., de Ruiter, H., Hora, M., Liesinger, L., Birner-Gruenberger, R., et al. (2019) · doi:10.1101/509109 · Cited by 29
Locus-specific LINE-1 mRNA expression reflects cell-type- and stimulus-specific senescence states
Tran, M. N., Liu, S., Baddoo, M., Stow, E. C., Srivastav, S. K., & Belancio, V. P. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag522
“Although the number of senescent cells increases with age and contributes to tissue degeneration and age-related diseases, they are also essential for tissue healing and healthy aging [ 42–49 ].”
Histone variant H2A.Z mutant suppresses the senescence-associated secretory phenotypePreprint
Chua, Z. M., Tanaka, H., Abele, A., Rajesh, A., Teneche, M. G., Lei, X., Miller, K. N., Davis, A., Macip, C. C., Haddadin, L., et al. (2026) · Research Square · doi:10.64898/2026.02.16.706244 · Cited by 1
Molecular imaging for senescent cells-targeted therapeutics in aging and age-related diseases
Cen, P. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.020
Vascular aging and cardiovascular diseases
Zhao, Y., Wu, A., LiYong, L. I. A. O., Liu, M., XueTing, G. O. N. G., & Tian, X. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2020-0344
Periodontitis: A Hastened and Destructive Inflammatory Induced Senescence
Younis, L. T., Bahnasi, F. I., Rahman, A. N. A. A., & Hassan, M. I. A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3764546
Rôle et régulation de l'haptoglobine adipocytaire au cours du vieillissement
Astre, G. (2018) · theses.fr (ABES) · doi:10.70675/91523d31z8a53z44e6z8f1dzf0a02840a7e5
Martínez‐Zamudio, R. I., & Herbig, U. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_38
Oxytosin as a novel antidegenerative?
Faragher, R. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18546
Pawelec, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734674689.793557283
Mechanisms of precocious ageing in a human progeroid syndrome
Molina, C. F. (2021) · theses.fr (ABES) · doi:10.70675/f78c9fa2z621cz48b6zbf00z1133c36b723a
Novel probes, carriers and prodrugs to target senescent cells in vivo
Lozano‐Torres, B. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/172175
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_8
Morihana, Y., Nakagawa, M., Zhou, Y., Morikuni, H., Deng, Z., Honda, Y., & Nishiura, A. (2026) · Biology · doi:10.3390/biology15020187 · Cited by 1
Pieters, J., & Mode, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735010803.793558622
SILAC Analysis Reveals a Role for the Senescence-Associated Secretory Phenotype in HemostasisPreprint
Wiley, C. D., Liu, S., Limbad, C., Zawadzka, A. M., Beck, J., Demaria, M., Artwood, R., Alimirah, F., Danielson, S. R., Oron, T. R., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155773
Mohammed, N. W. B., Baird, D. P., & O'Sullivan, E. D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1867121
Oncogene inactivation-induced senescence facilitates tumor relapse
Schmitt, P., Hönig, K., Norcia, M. T., Nogueira, M. F., Flore, V., Vesperinas, I. S., Villoro-Agud, M., Peng, L., Safyürek, Z., Tariq, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75021-9
Hunter, R. W. (2026) · Acta Physiologica · doi:10.1111/apha.70205
“This adds to the mystique of senolytic therapy, which has been shown in murine models to extend lifespan through pleiotropic mechanisms [9].”
PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines
Huart, C., den Abbeel, M. V., Schifflers, C., Bouhjar, K., Scarmelotto, A., Khelfi, A., Wéra, A.-C., & Michiels, C. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70206 · Cited by 1
“Up to now, senolytics have demonstrated positive effects in mouse models presenting atherosclerosis, osteoarthritis, cataracts, cardiac hypertrophy, renal dysfunction, lipodystrophy, and sarcopenia [23,25 – 28].”
L’âge des poumons : pas toujours celui des années ?
Guecamburu, M., Ahmed, E., Baptista, B. R., & Boyer, L. (2024) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(24)00006-5
Aging and Senescence Studies in Human and Zebrafish
Hirata, H., Tezuka, T., & Ujibe, K. (2024) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-97-2712-4_1
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
(2022) · doi:10.1101/2022.03.15.484520 · Cited by 12
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F. H., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.30.609895
Mposhi, A., Uvnäs‐Moberg, K., & Turner, J. D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103343
TERT-dependent senescence and inflammation in ageing, using zebrafish as a model
Martins, R. R. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Rath, P. C. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_13 · Cited by 1
Zhang, Q., Hu, D., Lin, Z., et al. (2024) · medRxiv · doi:10.1101/2024.08.26.24312564
Impact of aging on cardiac mesenchymal stromal cells
Martini, H. (2019) · theses.fr (ABES) · doi:10.70675/bb7ddcb3z0b6az4c39za6eczc94e0563f0a3
Phosphoproteome Profiling of Mouse Liver During Normal AgingPreprint
Liu, J., Wu, Y., Yang, Y.-H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-966762/v1
Staging concept for aging management: Definition, mechanism, and coping strategies
Wang, Z., Liu, S. S., Du, S., Cui, X., Chao, B., Liu, M., & Wu, M. (2026) · View · doi:10.1002/viw.20250201
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.